In India, healthcare providers initiate counselling and testing, diagnosis and treatment. They determine where you get tested, the shop you buy medicines from, which drugs you buy and which brands of these drugs. This is the background of the current debate on provider-initiated testing. According to the latest WHO guidance note , providers who believe that a patient is at risk of HIV may suggest a test for HIV. All testing for HIV, including provider initiated testing and counselling (PITC), may be done only in the following conditions: informed consent which includes the right to refuse, the availability of counselling with follow-up, and, in the event of a positive test result, treatment. Are these requirements for testing available in the Indian scenario?